Cardioncological Approach for Trastuzumab Therapy in Breast Cancer Patients With Cardiotoxicity: Impact on Adherence and Clinical Outcome

BACKGROUND: Treatment with Trastuzumab is associated with cardiotoxicity. If Trastuzumab could be administered in a safe manner to patients who develop a reduced left ventricular ejection fraction (EF) of < 50% remains poorly understood. OBJECTIVE: To evaluate the impact of a cardioncological app...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabiani, Iacopo, Cipolla, Carlo Maria, Colombo, Nicola, Cardinale, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417864/
https://www.ncbi.nlm.nih.gov/pubmed/32848791
http://dx.doi.org/10.3389/fphar.2020.01190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417864/
https://www.ncbi.nlm.nih.gov/pubmed/32848791
http://dx.doi.org/10.3389/fphar.2020.01190

Ejemplares similares